Susquehanna International Group, LLP Onconova Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$1.46 - $2.82 $26,134 - $50,478	-17,900 Reduced 61.51%	11,200 $21,000
Q4 2021 Feb 14, 2022	SELL	$2.49 - $3.73 $26,394 - $39,538	-10,600 Reduced 26.7%	29,100 $74,000
Q3 2021 Nov 15, 2021	BUY	$3.81 - $6.76 $151,257 - $268,372	39,700 New	39,700 $152,000

249K

Ticker ONTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,895,600
Market Cap $12.3M
Description
Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.